Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2026-03-26 @ 3:18 PM
Ignite Modification Date: 2026-03-26 @ 3:18 PM
NCT ID: NCT07488793
Eligibility Criteria: Inclusion Criteria: * 18 years of age or older * Diagnosis of SCI * Live within the community (not nursing facility) * Not actively engaged in physical activity for exercise * Not having the ability to participate in physical activity due to physical capacity or environmental barriers * Medically stable * Ability to obtain physician approval to participate in the study * Willingness to participate in a 2-day initial assessment visit at research testing location, 30 intervention sessions conducted independently by the participant or caregivers, 2-day post intervention assessment visit at research testing location. Exclusion Criteria: * Medically unstable * Have had a heart-related condition within the past year * Have had a blood clot in the past year * Have a stage 3 or 4 pressure injury * Have taken blood thinners in the past year * Have had surgery in the past year * Have uncontrolled hypertension * Have peripheral artery disease * Have Complex Regional Pain Syndrome (CRPS) in both arms * Have had nerve or tendon transfers in the arms in the past year * Have lymphedema in the arms * Have recent acute illness or injury (within the past 3 months) * Currently pregnant * Enrolled in another clinical trial * Are taking GLP-1 medications * Unable to provide consent * Currently engaged in physical activity for exercise
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Study: NCT07488793
Study Brief:
Protocol Section: NCT07488793